Navigation Links
Quest PharmaTech's Prostate Cancer Program Update

Trading Symbol: QPT: TSX Venture Exchange

EDMONTON, May 02, 2007 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") Quest is pleased to provide an update on the pre-clinical development of SL052 for the treatment of prostate cancer.

Prostate cancer is the second leading cause of cancer death in American men with approximately 230,000 new cases and 30,000 deaths per year. Current therapeutic modalities for localized prostate cancer are associated with significant morbidity, such as sexual and urinary dysfunction. Photodynamic therapy (PDT) is a minimally invasive treatment that may be used in benign and malignant prostate diseases. PDT is a dual selective treatment modality using light of a specific wavelength to locally activate a photosensitizer accumulated in the target tissue. This novel therapy causes a non-carcinogenic photochemical destruction of cancer cells, including those that are resistant to radiation and chemotherapy.

Quest's innovative Photodynamic Therapy (PDT) prostate cancer treatment system utilizes our patented Sonolight Technology, our proprietary and potent Hypocrellin based photosensitizer, SL052, with a novel intra-arterial drug delivery system and state of the art laser device that delivers pulsed light. Pre-clinical studies in small and large animals have demonstrated the effectiveness of SL052 in selective destruction of normal and cancerous prostate tissues, with minimal side effects. The use of 18 F FDG (flurodeoxy glucose) PET imaging pre and post PDT treatment, highlighted the complete shut down of metabolic activity at the tumor site 24 hours after PDT treatment.

The practical application of this new PDT treatment system on the prostate gland has also been demonstrated using a canine prostate model. The intra-arterial drug delivery system allows the selective and significant accumulation of the photosensitizer in the prostate which is ea
'"/>




Page: 1 2 3

Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
7. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
10. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quest PharmaTech Prostate Cancer Program Update
(Date:11/6/2009)...6 America,s Specialty M...up of mid-market and smaller innovator pharmaceuti... 3962, the "Affordable Health Care for America Act...hese smaller companies fear that the cumulative ef...der their efforts to bring new medicines to market...
(Date:11/6/2009)... NuVasive, Inc. (Nasdaq:...loping products for minimally disruptive surgical ...intment of Michael J. Lambert as Executive Vice Pr...ember 9, 2009. The Company also announced several...ichael will be an excellent complement to the NuVa...
(Date:11/6/2009)... Nov. 6 Philips Respironics applau...and Prevention (CDC) to raise awareness about an i...fficiency. The CDC,s release of the first-ever gov...s in sleeplessness is a milestone in quantifying t...-time educator, industry leader and sleep therapy ...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 1Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 2Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 3Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 4Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 5Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 6Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 7Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 8Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 1Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 2Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 4Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 5Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 6Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 7Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 8Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 10Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 11Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 12Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 13Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 14Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 15Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 16Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 17Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 18Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 19Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 20Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 21Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 22Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 23Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 24Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 25Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 26DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
..., N.J., Oct. 30 Leading researchers,will present ...hepatitis,products, including PEGINTRON(TM) (pegin...combination therapy, a current standard of care in... American Association for the,Study of Liver Disea...mong these are several studies discussing the pred...
...card Provides Hospital-Wide View of MRSA Infection...al provider of products and services that improve ...announced a new service to help,hospitals combat m...infections that are responsible for an estimated 9...s annually in the U.S.(1) Cardinal Health is depl...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 7Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 3
(Date:11/8/2009)...h Care Reform Bill ,, Critical legislation wo...Americans ,, CHICAGO, Nov. 7 /PRNewswire-USNew...entatives passed by a vote of 220-215, critical he... Medicare for seniors and end discrimination by in...s out of affordable health coverage. ,, The A...
(Date:11/7/2009)...swire/ -- Karen Ignagni, President and CEO of Amer...following statement today on House passage of H.R....hensive health care reform, and we have contribute...aul of how health insurance is provided. Earlier t...tion of pre-existing condition exclusions, no long...
(Date:11/7/2009)... Cook (GA), Louis J. Goodman (TX), Palmer P. Jones..., Nov. 7 The American M...cal society executive leaders with achievement awa...ideals of the medical profession. The awards were ...eeting in Houston. ,, (Logo: http://www.news...
(Date:11/7/2009)...responsibility to vigorously oppose abortion in he...ASHINGTON, Nov. 7 Am...the following statement on the news that Cardinal ...Affordable Health Care for America Act (H.R. 3962)...for abortion is voted upon. ,, "Our Catholic b...
(Date:11/7/2009)...ciety of America (PRSA) will bestow the distinguis...vice president of Brand Strategy, Communications a... at PRSA,s 2009 International Conference in San Di... Fellows is one of the profession,s highest indivi...ow PRSA, and 2009 chair of the College of Fellows....
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
... lesser mortals, with a lower life expectancy, unt...for the fair-sex. //In 2006 especially, there appe...women the world over, so much so that they seem to...tries, with lifestyles and smoking patterns being ...
...st 50 cattle are reported to have died in Madhya P...id Saturday.// Anthrax, an acute infectious d...lus anthracis, was first reported in the state in ...wer vertebrates like cattle, sheep, goats, camels,...
...ssengers on long haul flights sporting sunglasses,... for cover nor are they wearing it to enhance thei...e utility benefits and perhaps will score very hig... that sunglasses can help reduce jet lag. Now pass...
...tech firm TeGenero, the drugs company behind the c... its 12-page document prepared by Parexel. //This ...sly harm the immune system. The clinical trial le...ble effect of the drug was cytokine release. This ...
...eople need up to six times as much sunlight as tho...tamin D, says a new study// . Researchers at...r-skinned people need over four minutes in the sum...hing also depends on geography and the amount of s...
... Kerala food items, recipe displays and traditiona... three-day Spicy// Heritage of Kerala food festiva...ble to attract so many tourists because of the var...r of Tourism and Culture Ambika Soni said inaugura...
Other Medicine News:
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: